Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
The current price of MAYND is $1.91 USD — it has increased by +0% in the past 24 hours. Watch Mayne Pharma Limited stock price performance more closely on the chart.
What is Mayne Pharma Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mayne Pharma Limited stocks are traded under the ticker MAYND.
What is Mayne Pharma Limited revenue for the last year?▼
Mayne Pharma Limited revenue for the last year amounts to 300.38M USD.
What is Mayne Pharma Limited net income for the last year?▼
MAYND net income for the last year is -183.54M USD.
Does Mayne Pharma Limited pay dividends?▼
Yes, MAYND dividends are paid annual. The last dividend per share was 0.4 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Mayne Pharma Limited located?▼
Mayne Pharma Limited operates in the Manufacturing sector.
When did Mayne Pharma Limited complete a stock split?▼
Mayne Pharma Limited has not had any recent stock splits.
Where is Mayne Pharma Limited headquartered?▼
Mayne Pharma Limited is headquartered in Adelaide, AU.